ReviewPacing and clinical electrophysiology : PACE2026
Zero Fluoroscopy Catheter Ablation of Accessory Pathways and AV Nodal Re-Entry Tachycardia: A Single Institution Study.
Review in Pacing and clinical electrophysiology : PACE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMinimizing radiation exposure during electrophysiological studies remains an important priority in the catheterization laboratory. With the advancement of imaging and electroanatomic mapping systems, eliminating fluoroscopy from catheter ablation of arrhythmias is becoming more feasible, even for left side procedures requiring transseptal puncture. Nevertheless, there remain concern over the safety and efficacy of a zero-fluoroscopy approach.
objectivesThe aim of this report was to evaluate the safety and efficacy of a zero-fluoroscopy catheter ablation approach for accessory pathways and atrioventricular nodal-reentrant tachycardia (AVNRT) in a diverse, consecutive patient cohort.
methodsThis was a retrospective analysis of all patients who underwent radiofrequency ablation or cryoablation of accessory pathways or AVNRT between January 2019 and June 2022 at a single institution. Patient demographics, arrhythmia substrates, ablation energy modalities, and procedural outcomes were evaluated.
resultsThere were 166 total ablation procedures performed on 164 unique patients. Fluoroscopy was not used in any of the cases. The mean age was 14.8 years (range 3.1-35.7), of whom 84% were under 18 years of age. Among the 166 procedures performed, 58 involved only typical AVNRT, 1 atypical AVNRT, 99 were accessory pathways, and 8 involved multiple arrhythmia substrates. In all, there were 112 instances of accessory pathways (78 manifest, 34 concealed). Acute procedure success was 99.4%. There were five (5/164, 3%) recurrences after a year of follow-up. There were no complications identified.
conclusionZero-fluoroscopy approach to catheter ablation of AVNRT and accessory pathways is safe and effective, further supporting the general adoption of radiation-free techniques in such cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.